Investment
Features
FeesSafety
Academy
More
Pluang+
Asset icon - trade crypto, stocks, and gold on Pluang

Crowdstrike Holdings Inc (CRWD) Stock Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Core Scientific director Elizabeth Crain buys 6,000 shares, signaling confidence in the company.

Elizabeth Crain, a director at Core Scientific, has purchased 6,000 shares of the company. This insider buying may indicate her confidence in the company's future prospects. Such moves often attract investor attention as they can signal positive expe...

Market News
2 hours ago
Jack Delaney
Bullish
news icon
Core Scientific director Elizabeth Crain buys 6,000 shares, signaling confidence in the company.

Hyperscale Data shifts to AI data centers, signals undervaluation and insider confidence

Hyperscale Data has stopped Bitcoin mining to focus on AI data center services, backed by a $1.2 billion contract at its Michigan facility. The company's assets, including cash and Bitcoin, are worth nearly double its market cap, suggesting undervalu...

Market News
2 hours ago
Gordon Thompson
Bullish
news icon
Hyperscale Data shifts to AI data centers, signals undervaluation and insider confidence

Pharvaris stock jumps after positive HAE drug trial and Oppenheimer raises price target to $75

Pharvaris's experimental oral drug deucrictibant showed an 83% reduction in hereditary angioedema (HAE) attacks in a Phase 3 trial, prompting Oppenheimer to raise its price target from $50 to $75 and maintain an "Outperform" rating. The positive tria...

Market News
3 hours ago
Gordon Thompson
Bullish
news icon
Pharvaris stock jumps after positive HAE drug trial and Oppenheimer raises price target to $75

Inhibrx CEO buys shares after positive cancer drug trial results, showing strong confidence.

Inhibrx Biosciences CEO Lappe Mark purchased 5,895 shares at $99.29 each following positive Phase 2 trial results for their cancer drug INBRX-106 combined with Keytruda. The trial showed a 48.3% tumor response rate, nearly double that of Keytruda alo...

Market News
3 hours ago
Andrew Wynn
Bullish
news icon
Inhibrx CEO buys shares after positive cancer drug trial results, showing strong confidence.

Chewy expects Q2 2026 EPS of $0.36 and $3.32B revenue amid growth and cost challenges.

Chewy will report its Q2 2026 earnings on September 9, with analysts expecting earnings per share (EPS) of $0.36, a 9.1% increase year-over-year, and revenue of $3.32 billion, up 6.8%. Growth is driven by its Autoship subscription program and expansi...

Company Fundamentals
3 hours ago
Andrew Wynn
Neutral
Chewy expects Q2 2026 EPS of $0.36 and $3.32B revenue amid growth and cost challenges.

Edge Total Intelligence faces $2.6M revenue loss as Austal Australia drops key contracts, prompting leadership and strategy shifts.

Edge Total Intelligence announced that Austal Australia has not renewed certain contracts under the Strategic Shipbuilding Agreement, resulting in an estimated $2.6 million revenue loss over the next year. The company is reviewing financial impacts a...

Market News
4 hours ago
Newsfile Corp
Bearish
news icon
Edge Total Intelligence faces $2.6M revenue loss as Austal Australia drops key contracts, prompting leadership and strategy shifts.

Gold miners flush with cash poised for acquisition spree as record margins boost industry growth.

Gold miners have paid off debt, increased dividends, and bought back stock, leaving them with excess cash and no leverage to reduce. The next phase in the bull market is expected to be acquisitions, with major producers likely to buy large projects f...

Market News
4 hours ago
Kitco
Bullish
news icon
Gold miners flush with cash poised for acquisition spree as record margins boost industry growth.

Marvell credits trust for 241% stock surge, securing key AI partnerships with Nvidia and Google.

Marvell Technology's CEO Matt Murphy attributes the company's 241% stock rise over the past year to a decade-long build of trust with major tech firms. This trust has enabled Marvell to secure significant AI ecosystem partnerships, including deals wi...

Market News
4 hours ago
CNBC
Bullish
news icon
Marvell credits trust for 241% stock surge, securing key AI partnerships with Nvidia and Google.

Nike shares hit 12-year low amid margin pressure and risk of dividend cut

Nike's stock has fallen 50% to a 12-year low, yet remains overvalued with a forward P/E of 22.36x. The company faces ongoing margin compression, declining sales, and a free cash flow payout ratio exceeding 100%, raising concerns about a potential div...

Market News
4 hours ago
Seeking Alpha
Bearish
news icon
Nike shares hit 12-year low amid margin pressure and risk of dividend cut

Mariposa County prioritizes mining in economic plan, boosting Lode Gold's Fremont project prospects.

Mariposa County has chosen mining as the first sector to focus on in its economic development initiative, aiming to strengthen and diversify the local economy. Lode Gold Resources welcomes this move, as it supports advancing the Fremont Gold Mine Pro...

Market News
4 hours ago
Newsfile Corp
Bullish
news icon
Mariposa County prioritizes mining in economic plan, boosting Lode Gold's Fremont project prospects.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

Key Stats

  • Market Cap
    $218.20B
  • Volume
    -
  • Sector
    Technology
  • 52W High
    $231.00
  • 52W Low
    $87.56
  • Typical Hold Time
    -
  • Enterprise Value
    $214.01B
  • Div Yield
    -
  • Trading Activity
    -
$209.5
52W Low: $87.56
24 Feb 2026
52W High: $231
31 Aug 2026

Track Crowdstrike Holdings Inc (CRWD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Crowdstrike Holdings Inc has traded between a low of $87.56 and a high of $231, highlighting its annual price range. Buy and sell Crowdstrike Holdings Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!